- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Lenalidomide, Bortezomib
Total 1840 results
-
Groupe Francophone des MyelodysplasiesUnknownMyelodysplastic SyndromesFrance
-
National Cancer Institute (NCI)Millennium Pharmaceuticals, Inc.Withdrawn
-
Masonic Cancer Center, University of MinnesotaMerck Sharp & Dohme LLC; Millennium Pharmaceuticals, Inc.TerminatedLeukemia | Myelodysplastic SyndromeUnited States
-
National Cancer Institute (NCI)CompletedSarcoma | Lymphoma | Neuroblastoma | WilmsTumorUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Completed
-
Milton S. Hershey Medical CenterUnknownMantle Cell LymphomaUnited States
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)TerminatedMelanoma | Solid Tumor | Brain and Central Nervous System TumorsUnited States
-
University of Medicine and Dentistry of New JerseyNational Cancer Institute (NCI)CompletedBreast Cancer | Head and Neck Cancer | Colorectal Cancer | Pancreatic Cancer | Ovarian Cancer | Lung Cancer | Prostate Cancer | Unspecified Adult Solid Tumor, Protocol Specific | Melanoma (Skin)United States
-
M.D. Anderson Cancer CenterSanofiRecruitingMultiple MyelomaUnited States
-
Beijing InnoCare Pharma Tech Co., Ltd.Recruiting
-
Peking Union Medical College HospitalRecruiting
-
Seoul National University HospitalRecruitingRelapsed/Refractory Diffuse Large B Cell LymphomaKorea, Republic of
-
CelgeneCompletedMyelodysplastic SyndromesUnited States, Germany
-
University Hospital, ToulouseCelgene; Intergroupe Francophone du MyelomeCompleted
-
The Cleveland ClinicNational Cancer Institute (NCI)CompletedKidney CancerUnited States
-
St. Joseph's Hospital and Medical Center, PhoenixTexas Tech UniversityNot yet recruitingCognitive Dysfunction | Neurodegenerative Disease, Hereditary | Cognitive Impairment, Mild | Amyloid Plaque | Inflammation, Brain
-
MorphoSys AGCompletedDiffuse Large B-cell LymphomaBelgium, Germany, United States, Austria, Czechia, France, Italy, Portugal, Spain
-
CelgeneCompletedChronic Lymphocytic Leukemia | Leukemia, B-Cell, ChronicCanada, United States, Germany, Italy, Spain, Sweden, United Kingdom
-
Innate PharmaCompletedPatients With Multiple Myeloma Experiencing a | First or Second RelapseUnited States
-
Peter MacCallum Cancer Centre, AustraliaCelgene CorporationUnknownMyelodysplasiaAustralia
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Beth Israel Deaconess Medical Center; Brigham... and other collaboratorsCompletedGlioblastoma | Gliosarcoma | Malignant GliomasUnited States
-
Starton Therapeutics, IncRecruitingMultiple MyelomaUnited States
-
European Myeloma NetworkFondazione EMN Italy OnlusCompleted
-
National Cancer Institute (NCI)Terminated
-
Rasim GucalpMillennium Pharmaceuticals, Inc.TerminatedNon-small Cell Lung CancerUnited States
-
Columbia UniversityCelgene CorporationActive, not recruiting
-
The Lymphoma Academic Research OrganisationCelgene CorporationCompletedRelapsed/Refractory B-cell LymphomaFrance
-
Celgene CorporationCompletedMyelodysplastic SyndromesUnited States, Denmark, Australia, Belgium, Czech Republic, France, Germany, Greece, Italy, Netherlands, Russian Federation, Spain, Sweden, Switzerland, United Kingdom
-
Southern Europe New Drug OrganizationCelgene CorporationUnknown
-
Hospital General de MexicoRecruitingAcute Lymphoblastic Leukemia, in Relapse | Chemotherapeutic Toxicity | Minimal Residual DiseaseMexico
-
Shahid Beheshti University of Medical SciencesRecruitingAntibody-mediated RejectionIran, Islamic Republic of
-
Beijing Chao Yang HospitalEnrolling by invitationMultiple Myeloma | BortezomibChina
-
University of Michigan Rogel Cancer CenterCompletedLymphoma, Non-Hodgkin | Hodgkin's LymphomaUnited States
-
Sidney Kimmel Cancer Center at Thomas Jefferson...CompletedGraft-versus-Host DiseaseUnited States
-
PETHEMA FoundationCompleted
-
Cancer Trials IrelandSanofi; Dana-Farber Cancer InstituteRecruitingMultiple MyelomaDenmark, Ireland
-
Janssen Research & Development, LLCCompleted
-
Massachusetts General HospitalCompletedMultiple MyelomaUnited States
-
Duke UniversitySpectrum Pharmaceuticals, IncTerminated
-
National Cancer Institute (NCI)TerminatedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
GlaxoSmithKlineWithdrawn
-
AHS Cancer Control AlbertaAbbott; Tom Baker Cancer CentreCompleted
-
Dana-Farber Cancer InstituteMillennium Pharmaceuticals, Inc.CompletedChronic Graft Versus Host DiseaseUnited States
-
University Health Network, TorontoCelgene CorporationCompleted
-
Yale UniversityCelgene CorporationTerminatedChronic Lymphocytic LeukemiaUnited States
-
National Institutes of Health Clinical Center (CC)National Cancer Institute (NCI)CompletedLymphoma | Small Intestine Cancer | Unspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Celgene CorporationCompletedRadiculopathyUnited States
-
SCRI Development Innovations, LLCNovartisTerminated
-
University of ChicagoNational Cancer Institute (NCI)Completed